Compounds and compositions as protein kinase inhibitors | Patent Number 09850229

US 09850229 B2
Application Number15179385
Publication NumberUS 20160280686 A1
Pendency1 year, 6 months, 19 days
Filled DateJun 10, 2016
Priority DateAug 28, 2009
Publication DateSep 29, 2016
Expiration DateAug 27, 2029
Inventor/ApplicantsZuosheng Liu
John Tellew
Yongqin Wan
Xing Wang
Xianming Jin
Shenlin Huang
Daniel Poon
Yongping Xie
ExaminesBORI, IBRAHIM D
Art Unit1629
Technology Center1600
Assignments
Array Biopharma
Current
Array BiopharmaPfizer
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.